SCHEMBL6650883

SCHEMBL6650883

Fc1cc(N2CCNCC2)ccc1-c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 7/20 0.59
HTR1A P08908 5/20 0.59
HTR3E A5X5Y0 2/20 0.53
HTR3B O95264 2/20 0.53
HTR3A P46098 2/20 0.53
HTR3D Q70Z44 2/20 0.53
HTR3C Q8WXA8 2/20 0.53
SIGMAR1 Q99720 2/20 0.53
ADRB1 P08588 2/20 0.53
HTR5A P47898 2/20 0.53
HTR6 P50406 2/20 0.53
HTR2A P28223 1/20 0.53
KHK P50053 1/20 0.51
PDK2 Q15119 1/20 0.49
HTR2C P28335 1/20 0.48
LTA4H P09960 1/20 0.47
FGFR1 P11362 1/20 0.46
FGFR2 P21802 1/20 0.46
ACVR1 Q04771 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4909484 0.88 HTR7 (0.59) HTR7HTR1AHTR3EHTR3BHTR3A
SCHEMBL18411537 0.85 PDK2 (0.46) HTR7HTR1APDK2
SCHEMBL6650889 0.81 HTR7 (0.58) HTR7HTR1AHTR3EHTR3BHTR3A
SCHEMBL3267995 0.81 HTR7 (0.69) HTR7HTR1AHTR3EHTR3BHTR3A
SCHEMBL7491691 0.79 HTR1A (0.36) HTR7HTR1AHTR3AHTR5AHTR6
SCHEMBL1874346 0.79 VCP (0.46) KHKPDK2
SCHEMBL1200196 0.79 HTR1A (0.48) HTR7HTR1AHTR3EHTR3BHTR3A
SCHEMBL7591669 0.78 HTR7 (0.67) HTR7HTR1AHTR3EHTR3BHTR3A
SCHEMBL478208 0.78 ADRB1 (0.57) HTR7HTR1AHTR3EHTR3BHTR3A
Hydrochloric Acid SCHEMBL8318106 0.76 ADRB1 (0.55) HTR7HTR1AHTR3EHTR3BHTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1997370-B Use of N-sulfamoyl-N' -arylpiperazines for the production of medicaments for the prophylaxis or treatment of obesity and related diseases SOLVAY PHARM BV 2011-06-01 CN disclosed
CN-1997370-A Medicaments containing N-sulfamoyl-N' -arylpiperazines for the prophylaxis or treatment of obesity and related diseases SOLVAY PHARM GMBH (DE) 2007-07-11 CN disclosed
EP-1447099-A2 Antineoplastic polyethylene conjugates of cytostatic compounds and pharmaceuticals comprising same Kratz, Felix (DE) 2004-08-18 EP disclosed
EP-0934081-B1 ANTINEOPLASTIC CONJUGATES OF ALBUMIN KRATZ FELIX (DE) 2004-06-09 EP disclosed
EP-1389194-A2 INHIBITORS OF BACE VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-02-18 EP disclosed
WO-2002088101-A2 INHIBITORS OF BACE VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-11-07 WO disclosed